Insife’s growing global presence brings expansion to the UK

Hellerup, Denmark: Pharmacovigilance consulting and technology services specialist Insife has opened a new UK based affiliate located in Cambridge.

Continued expansion

The opening of the UK office is in line with Insife’s business model of expansion into pharmaceutical markets where its products and services are in demand. The UK affiliate joins sites in the USA, Germany and India, alongside its headquarters near Copenhagen.

The Cambridge operation is intended to both expand Insife’s presence in Europe and to better serve the needs of its UK-based clients.

New opportunities

Insife founder and CEO, Martin Holm-Petersen, commented: “Insife’s growth is exciting, and brings new opportunities and additional benefits for current and potential clients”.

“Our workforce has expanded 50 percent over the past year and as we grow, both in scale and in capability, we are able to meet global market challenges, including this expanded footprint in the UK,” Mr. Holm-Petersen added.

About Insife

Founded in 2017, Insife offers specialist consulting services in pharmacovigilance (PV), regulatory affairs (RA), technology and IT, delivering innovative solutions and insights to pharma and life sciences companies in Europe, North America and Asia.

Insife services are based on expertise across the pharma value chain with an understanding of the potential for digital transformation in the life sciences industry and drug safety assurance through process optimization and automation.

Insife provides a portfolio of proven and scalable end-to-end (E2E) business process, organization and technology solutions that have been applied across a spectrum of clients ranging from medium and small size businesses to the Pharma Top 25.

These offerings include E2E Drug Safety Consulting and Technology services, the proprietary HALOPV global safety database, AI Data Analyzer tool that applies AI technology to unstructured data sets, and Insife.cloud, an innovative cloud-based IT platform that provides a total one-stop-shop for pharmacovigilance drug safety and GxP compliance.

Over its first three years of operations, Insife has been growing revenues at an average rate of 300% annually, and now has additional offices in the US, India, Germany and the UK.

Find out more at:  www.Insife.com and www.halopv.com

Resources

Click on Insife News and Media for further information.